Related Experiment Video
Updated: Mar 7, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes
Amy D Proal1, Inge A Lindseth2, Trevor G Marshall1
1Autoimmunity Research Foundation, Thousand Oaks, CA 91360, USA.
The human microbiome, including bacteria and viruses, interacts with our genes to regulate metabolism. Imbalances in these microbial communities, known as dysbiosis, are linked to various inflammatory and autoimmune conditions.
Area of Science:
- Microbiology
- Immunology
- Genetics
Background:
- The human body hosts a vast microbiome of bacteria, viruses, fungi, and bacteriophages across all sites, including tissues and blood.
- Microbial genomes interact with human genomes, regulating host metabolism and exhibiting both commensal and pathogenic capabilities.
- Inflammatory conditions like autoimmune, neurological, and malignant diseases are increasingly linked to microbial ecosystem dysbiosis.
Purpose of the Study:
- To explore the role of the collective microbiome activity in driving inflammatory processes.
- To understand the complex microbe-microbe and host-microbe interactions contributing to disease.
- To elucidate how microbial communities evade immune responses and dysregulate host gene expression.
Main Methods:
- Analysis of population-based microbiome studies.
- Investigation of microbe-microbe interactions within polymicrobial communities.
- Examination of host-microbe interactions, including intracellular persistence and molecular mimicry.
Main Results:
- Microbial communities employ strategies like forming polymicrobial entities to evade immune detection.
- Pathogens within communities can enhance collective virulence through altered gene expression.
- Microbes residing within immune cells can directly disrupt host cellular processes like transcription and DNA repair.
Conclusions:
- Host-microbe interactions, including molecular mimicry and pathogen-secreted molecules, dysregulate human gene expression, promoting imbalance and immunosuppression.
- The collective activity of the microbiome, through intricate interactions, drives metabolic dysfunction characteristic of inflammatory conditions.
- Understanding microbiome dysbiosis is crucial for addressing a wide range of inflammatory and autoimmune diseases.
More Related Videos
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
09:49Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
Published on: November 18, 2022
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Inflammation
Microorganisms in Medicine and Therapeutics
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...